Published on:

Lawsuit Funding Supports Medical Malpractice Cases

One might find it hard to imagine that a doctor could amputate the wrong leg or remove the wrong kidney, but it does happen. When such medical negligence occurs, the resulting damages are irreparable. Unfortunately, most medical errors are not this “cut and dry.” Many cases involve multiple parties and because of the complex nature of medical malpractice cases, they take longer to reach trial – on average 3 – 5 years – than a victim has time to wait.

Medical malpractice victims often have serious financial issues directly related to damages incurred. Medical expenses and lost income often cause financial hardship and put victims and their families in a downward financial spiral. Creditors don’t care if a plaintiff can’t work or lost income from a deceased loved one; they only care about getting paid. When this happens, it is not uncommon for a plaintiff to seek litigation funding to mitigate these economic hardships.

Lawsuit Financial helps plaintiffs lessen their financial burdens while they wait for a favorable recovery in their case by providing a cash advance against the pending claim. Litigation funding is based on the merits and strengths of the lawsuit, not personal credit or work history. Once approved, funds can be used at the plaintiff’s discretion, although it is recommended to be use to pay medical bills, funeral and burial expenses, and other pressing bills.

Applying for medical malpractice litigation fundinghttps://www.lawsuitfinancial.com/lawyer-attorney-1307789.html is fast and free. With no need for credit checks or employment verifications, approval can be made quickly and funds available within 24 – 48 hours of approval. Best of all, litigation funding is risk-free; the plaintiff only repays the advance after winning the case and if the plaintiff loses, no repayment is required.

If you are in a medical malpractice lawsuit and need fast cash, begin your road to financial freedom by calling Lawsuit Financial or visiting us online.